Subsidy Tracker Parent Company Summary
Parent Company Name:
Bausch Health
Ownership Structure:
publicly traded (ticker symbol BHC)
Headquartered in:
Canada
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
|---|---|---|
| State/Local | $77,372,100 | 54 |
| Federal (grants and allocated tax credits) | $1,097,306 | 4 |
| TOTAL | $78,469,406 | 58 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards:
Earliest year of data: 2003. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2012.
Time Period for Federal Awards:
FY2000 to the present
Notes:
Dollar totals do not include awards for which no subsidy value is disclosed.
Links:
For a summary of this company's regulatory violations see its Violation Tracker summary page here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
|---|---|---|
| New Jersey | $47,327,600 | 3 |
| New York | $25,357,247 | 21 |
| North Carolina | $3,794,046 | 21 |
| South Carolina | $615,965 | 1 |
| Florida | $237,288 | 4 |
| All other | $39,954 | 4 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Download results as 
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
| Company | Location | Subsidy Source | Year |
Subsidy Value |
Loan/Bailout Value | Type of Subsidy |
|---|---|---|---|---|---|---|
| Biovail Americas Corporation and subsidiaries | New Jersey | state | 2013 | $39,502,500 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | state | 2015 | $9,000,000 | tax credit/rebate | |
| Valeant Pharmaceuticals North America LLC and | New Jersey | state | 2003 | $4,325,100 | grant | |
| Bausch & Lomb Incorporated | New Jersey | state | 2008 | $3,500,000 | grant | |
| Bausch & Lomb Incorporated(2) | New York | state | 2019 | $3,000,000 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | state | 2006 | $1,599,567 | enterprise zone | |
| Bausch & Lomb Incorporated | New York | state | 2010 | $1,517,457 | enterprise zone | |
| Bausch & Lomb Incorporated | New York | state | 2011 | $1,490,125 | enterprise zone | |
| Bausch & Lomb Incorporated | New York | state | 2012 | $1,416,700 | enterprise zone | |
| Bausch & Lomb Incorporated | New York | state | 2008 | $1,187,088 | enterprise zone | |
| Bausch & Lomb Incorporated | New York | state | 2009 | $1,169,891 | enterprise zone | |
| Bausch & Lomb Incorporated | New York | state | 2007 | $1,123,304 | enterprise zone | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2013 | $1,077,666 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2013 | $1,077,666 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | local | 2015 | $709,291 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | state | 2005 | $680,000 | enterprise zone | |
| BAUSH & LOMB | South Carolina | state | 2010 | $615,965 | training reimbursement | |
| Bausch & Lomb R&D | New York | local | 2006 | $605,264 | tax credit/rebate; property tax abatement | |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2006 | $489,383 | federal grant | |
| Bausch & Lomb Incorporated | New York | local | 2016 | $446,809 | tax credit/rebate | |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2005 | $421,273 | federal grant | |
| Bausch & Lomb Incorporated | New York | state | 2013 | $375,037 | enterprise zone | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2015 | $271,549 | tax credit/rebate | |
| Bausch & Lomb | New York | local | 2003 | $266,156 | tax credit/rebate; property tax abatement | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2014 | $253,035 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2014 | $253,035 | tax credit/rebate | |
| Bausch & Lomb | New York | local | 2004 | $214,683 | tax credit/rebate; property tax abatement | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2015 | $203,458 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2014 | $185,492 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | local | 2017 | $150,152 | tax credit/rebate | |
| Bausch & Lomb | New York | local | 2005 | $145,551 | tax credit/rebate; property tax abatement | |
| Bausch & Lomb Incorporated - Clearwater Facility | Florida | state | 2005 | $135,000 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | Local | 2018 | $119,960 | tax credit/rebate | |
| Bausch & Lomb Incorporated | New York | local | 2019 | $119,959 | tax credit/rebate | |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2004 | $100,000 | federal grant | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2011 | $96,902 | tax credit/rebate | |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2005 | $86,650 | federal grant | |
| Valeant Pharmaceuticals International | North Carolina | state | 2016 | $82,963 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2010 | $68,808 | tax credit/rebate | |
| Bausch & Lomb | Florida | state | 2010 | $50,000 | training reimbursement | |
| Bausch & Lomb | Florida | state | 2012 | $47,493 | training reimbursement | |
| Valeant Pharmaceuticals International | North Carolina | state | 2013 | $47,287 | tax credit/rebate | |
| Valeant Pharmaceuticals International | North Carolina | state | 2013 | $47,287 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2016 | $39,370 | tax credit/rebate | |
| Valeant Pharmaceuticals International | North Carolina | state | 2015 | $27,309 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2011 | $21,024 | tax credit/rebate | |
| Bausch & Lomb Inc. | New York | local | 2019 | $20,253 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2011 | $15,000 | tax credit/rebate | |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2008 | $10,777 | tax credit/rebate | |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2009 | $10,777 | tax credit/rebate | |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2010 | $10,777 | tax credit/rebate | |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2013 | $8,650 | tax credit/rebate | |
| Bausch & Lomb Incorporated | Massachusetts | state | 2011 | $7,623 | tax credit/rebate | |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2013 | $5,646 | tax credit/rebate | |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2013 | $5,646 | tax credit/rebate | |
| Buasch & Lomb | Florida | local | 2005 | $4,795 | grant | |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2015 | $3,313 | tax credit/rebate | |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2016 | $2,940 | tax credit/rebate | |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2004 | undisclosed | tax credit/rebate | |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2005 | undisclosed | tax credit/rebate | |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2008 | undisclosed | tax credit/rebate | |
| MEDICIS THE DERMATOLOGY CO | California | local | 2012 | undisclosed | tax credit/rebate |
Download results as or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
